subject area of
- CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis Journal Articles
- Downregulation of neutral endopeptidase (EC 3.4.24.11) in the inflamed rat intestine Journal Articles
- Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure Journal Articles
- Evidence for an effector role of endothelin in closure of the ductus arteriosus at birth Journal Articles
- Expression of common acute lymphoblastic leukemia-associated antigen on germ cell tumor Journal Articles
- Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema Journal Articles
- Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study Journal Articles
- Neuroimmunomodulation: classical and non-classical cellular activation Journal Articles
- Neutral endopeptidase (EC 3.4.24.11) downregulates the onset of intestinal inflammation in the nematode infected mouse Journal Articles
- Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P Journal Articles
- Primitive Nonneural Granular Cell Tumor (So-called Atypical Polypoid Granular Cell Tumor). Report of 2 Cases With Immunohistochemical and Ultrastructural Correlation Journal Articles
- Recent advances on endopeptidase-3.4.24.16 Journal Articles
- The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications Journal Articles
- The PROVE-HF Study: Additional Proof for the Inclusion of the Manufacturer’s Name When Reporting B-Type Natriuretic Peptide Results Journal Articles